Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.35
- Piotroski Score 3.00
- Grade Buy
- Symbol (EXAS)
- Company Exact Sciences Corporation
- Price $53.08
- Changes Percentage (0.72%)
- Change $0.38
- Day Low $52.17
- Day High $54.06
- Year High $79.62
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $80.00
- High Stock Price Target $168.00
- Low Stock Price Target $60.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.31
- Trailing P/E Ratio -32.77
- Forward P/E Ratio -32.77
- P/E Growth -32.77
- Net Income $-204,149,000
Income Statement
Quarterly
Annual
Latest News of EXAS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Gov. Abbott outlines Texas' massive offer to aid Trump's deportations, fires back at 'resistance' governors
Texas Governor Greg Abbott discusses the state's support for Trump administration's mass deportations and fight against the Chinese Communist Party. Texas offers land for deportation purposes, part of...
By Fox News | 1 day ago -
Texas A&M-CC hosts UT Martin after Williams' 21-point game
Isaac Williams led Texas A&M-CC with 21 points in their close loss to New Mexico State. The Islanders finished 21-12 overall with a strong home record. UT Martin had a 21-11 season with a 9-7 road rec...
By AP NEWS | 1 day ago -
Texas officials back optional school curriculum with Biblical references, sparking backlash
Patriot Mobile's Leigh Wambsganss and Senator Bryan Hughes support patriotic posters in Texas. Texas officials back an elementary curriculum with Biblical references, sparking debate over potential re...
By Fox News | 1 day ago
